L949-1353 Screening compound: 2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide

L949-1353 Screening compound: 2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide
L949-1353 Screening compound: 2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L949-1353
2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L949-1353

Molecular Formula

C18H17ClN4O3 (C18 H17 ClN4 O3)

Compound Name

2-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide

IUPAC name

2-[3-(3-chlorophenyl)-124-oxadiazol-5-yl]-N-[(furan-2-yl)methyl]pyrrolidine-1-carboxamide

SMILES

O=C(NCc1ccco1)N(CCC1)C1c1nc(-c2cccc(Cl)c2)no1

InChI

InChI=1S/C18H17ClN4O3/c19-13-5-1-4-12(10-13)16-21-17(26-22-16)15-7-2-8-23(15)18(24)20-11-14-6-3-9-25-14/h1,3-6,9-10,15H,2,7-8,11H2,(H,20,24)/t15-/m0/s1

InChI Key

RTRNOYJLJQGAKQ-HNNXBMFYSA-N

MDL Number (MFCD)

MFCD27489275

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.81

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.339

Distribution Coefficient, logD

4.339

Water Solubility, LogSw

-4.57

Polar Surface Area

66.244

Acid Dissociation Constant (pKa)

14.83

Base Dissociation Constant (pKb)

-2.15

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.80

L949-1353 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L949-1353 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L949-1353?
Check Price and Availability of L949-1353, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L949-1353 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L949-1353
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L949-1353
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L949-1353 available by request